Responding to the need for expanded knowledge on emerging trends, novel treatment approaches and outcomes for patients with AL and ATTR amyloidosis, JACC: CardioOncology will publish a special focus issue on this topic in 2021. Original research submissions spanning the theme will be considered, including those examining epidemiology, diagnosis and prognosis, clinical management, phenotyping, pathophysiology, emerging therapies, comorbidities, the role of imaging and biomarkers, and other relevant issues. Submissions are due on or before April 15, 2021. Publication is planned for the 2021 Winter issue.

See instructions for submitting and sign up for Journal email alerts to stay up to date on new issues and announcements.